ArticleJournal of thoracic disease2026
Survival risk prediction for patients with lung adenocarcinoma containing micropapillary components based on weakly supervised pathomics.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The presence of a micropapillary component is an independent adverse prognostic predictor for patients with lung adenocarcinoma. This study aimed to develop a pathomics model based on weakly supervised deep learning to accurately predict postoperative survival risk in patients with lung adenocarcinoma containing micropapillary components by analyzing whole slide images. Methods: Hematoxylin and eosin (H&E) stained whole slide images from 202 patients with lung adenocarcinoma containing micropapillary components who underwent surgical resection were retrospectively collected. A weakly supervised learning framework was adopted, utilizing ResNet18 and vision transformer (ViT) architectures to extract morphological features at the tile level, which were then aggregated to the patient level via multi-instance learning. Least absolute shrinkage and selection operator (LASSO) regression was employed to screen key pathomic features and construct a pathomics prediction model, which was compared with traditional models based on clinicopathological factors. Ultimately, the optimal pathomic features and clinically independent risk factors were integrated to establish a combined predictive nomogram. Results: Among the deep learning models, ResNet18 demonstrated superior feature extraction capability, with area under the curve (AUC) values of 0.934 and 0.653 in the training and test sets, respectively, outperforming the ViT model. Consequently, the ResNet18 model was selected, yielding 206 extracted features. Following LASSO regression, four key pathomic features were retained. A logistic regression (LR) model built upon these features achieved an AUC of 0.892 in the training set. Univariate and multivariate analyses of clinical variables identified eight significant features, including micropapillary and solid components, for modeling. The clinical feature model constructed using LR achieved AUCs of 0.872 and 0.698 in the training and test sets, respectively. The final combined clinicopathological nomogram significantly improved predictive performance in the training set (AUC =0.945), surpassing both the standalone pathomics and clinical models, and maintained reasonable discriminative ability in the test set (AUC =0.687). Visual analysis using Gradient-Weighted Class Activation Mapping (Grad-CAM) indicated that the model's decisions were focused on regions rich in micropapillary structures, enhancing interpretability. Conclusions: Weakly supervised deep learning methods can effectively identify digital pathological features associated with prognosis. A combined model integrating pathomic features with clinical information demonstrated stronger predictive power than models based solely on pathology or clinical data, offering a potential auxiliary tool for individualized postoperative risk stratification in patients with lung adenocarcinoma containing micropapillary components.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.